前叶与后叶二尖瓣修复的倾向匹配分析
本研究通过倾向评分匹配比较退行性二尖瓣病变行前叶修复(含双叶)与孤立后叶修复的长期结局。结论认为前叶与后叶修复的长期生存和再手术无差异,卓越中心应以相同决策阈值力求修复前、后叶病变而非置换。
要点
- 前叶修复(含双叶)与孤立后叶修复的长期生存无差异。
- 15年再手术累积发生率前叶7.5%、后叶4.9%,差异无统计学意义。
- 卓越中心对退行性二尖瓣前、后叶病变应同等倾向修复而非置换。
核心结论
- 前叶与后叶二尖瓣修复在长期生存和再手术方面无差异。
研究设计与样本
- 1992至2018年首次退行性二尖瓣修复患者,1:1倾向评分匹配后前叶修复309例(孤立前叶85例、双叶224例)与孤立后叶修复309例。
临床怎么用
- 卓越中心对退行性二尖瓣前叶和后叶病变应采用相同的决策阈值,优先选择修复而非置换。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Mitral valve repair is superior to replacement for degenerative disease, but long-term outcomes of anterior versus posterior leaflet repair remain poorly defined. We propensity matched anterior and posterior repairs to compare long-term outcomes. METHODS: Patients undergoing first-time degenerative mitral repair between 1992 and 2018 were identified. Primary outcome was overall survival. Secondary outcomes were postprocedural residual mitral regurgitation and reoperation. From 1025 patients, 1:1 propensity score matching was performed, yielding 309 anterior (isolated anterior = 85, bileaflet = 224) and 309 isolated posterior repairs. RESULTS: Age was 58 ± 15 years, ejection fraction was 57% ± 10%, and matched groups were well balanced. Anterior repairs had longer bypass (122 ± 53 vs 109 ± 43 minutes, P = .001) and crossclamp (94 ± 44 vs 85 ± 62 minutes, P = .033) times. Mean residual mitral regurgitation grade was 0.44 (95% confidence interval, 0.24-0.65) for anterior repair and 0.30 (95% confidence interval, 0.13-0.47) for posterior repair (P = .31). Overall, 92% (569/618) of matched patients had no residual mitral regurgitation, with no differences in mitral regurgitation grade between groups (P = .77). Survival did not differ between anterior (10 years: 72% ± 7%; 15 years: 63% ± 7%) and posterior (10 years: 74% ± 7%; 15 years: 60% ± 8%) groups (log-rank P = .93). Linearized incidence of reoperation was 0.62% per patient-year, including 0.74% for anterior and 0.48% for posterior repairs. Cumulative incidence of reoperation at 15 years was 7.5% after anterior repair and 4.9% after posterior repair (Gray's test P = .26). CONCLUSIONS: No long-term survival or reoperation difference was found between posterior and anterior repair. On the basis of these findings, surgeons at centers of excellence should aim for repair of both anterior and posterior leaflet pathology with the same decision-making threshold over valve replacement for degenerative mitral disease.
引用
- Brescia AA, Watt TMF, Rosenbloom LM, et al. Anterior versus posterior leaflet mitral valve repair: A propensity-matched analysis. J Thorac Cardiovasc Surg. 2020. PMID: 32305185. doi:10.1016/j.jtcvs.2019.11.148
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。